Stephane Angers

Title: The Innovative Contributions of Stephane Angers

Introduction

Stephane Angers is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of microfluidic devices and novel protein-binding agents. With a total of four patents to his name, Angers continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Angers' latest patents include advancements in microfluidic devices and methods of use. These devices are designed for high throughput phenotypic separation of magnetically labeled cell samples. The technology allows for the sorting of cells based on the level of target markers, which is particularly useful in isolating target cells and putative genetic modifiers during CRISPR screening and other large-scale cell screening processes. Another significant patent involves Frizzled5 protein-binding agents, which are aimed at treating diseases associated with aberrant expression or activity of Frizzled proteins. These novel agents and their methods of use represent a promising avenue for therapeutic development.

Career Highlights

Throughout his career, Angers has worked with prestigious institutions, including the University of Toronto and Modmab Therapeutics Corporation. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Angers has collaborated with notable colleagues such as Jason Moffat and Guohua Pan. These partnerships have further enhanced his research capabilities and have led to significant advancements in his projects.

Conclusion

Stephane Angers is a prominent figure in the field of biotechnology, with a focus on innovative solutions for cell sorting and disease treatment. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and improving healthcare outcomes.